Journey Medical Corporation Profile Avatar - Palmy Investing

Journey Medical Corporation

Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for …

Drug Manufacturers - Specialty & Generic
US, Scottsdale [HQ]
Major Shareholders · Proxy Ben. Owners

Shareholders

Breakdown
Journey Medical Corporation can't present any analysts estimates at the moment detail analysis.
Intraday
Shares Outstanding
20,889,935
Volume
34,136
Volume on Avg.
111,322
Beneficial Owners Beta
SEC Source
Owner Shares Equivalence - $3.84 per share Last Form/Filing Last Transaction
10% Holder
- No data -
Officers/Directors Below 10%
- No data -
End of DERM's Analysis
CIK: 1867066 CUSIP: 48115J109 ISIN: US48115J1097 LEI: - UEI: -
Secondary Listings
DERM has no secondary listings inside our databases.